|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
|
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Gross profit | |||
| Operating expenses: | |||
| Sales and marketing | |||
| Research and development | |||
| General and administrative | |||
| Change in fair value of contingent consideration | |||
| Total operating expenses | |||
| Loss from operations | |||
| Change in fair value of preferred stock warrant | |||
| Interest income | |||
| Interest expense | |||
| Interest income (expense), net | |||
| Other expense, net | |||
| Loss before provision for income taxes | |||
| Provision for income taxes | |||
| Net loss | |||
| Accretion of redeemable convertible preferred stock | |||
| Deemed dividend—preferred stock modification | |||
| Net loss attributable to common stockholders | |||
| Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) | |||
| Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted (in shares) |
Loading...